Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Prescriptions for estrogen replacement therapy in Ontario before and after publication of the Women's Health Initiative Study.

Austin PC, Mamdani MM, Tu K, Jaakkimainen L.

JAMA. 2003 Jun 25;289(24):3241-2. No abstract available.

PMID:
12824204
2.
3.
4.

Hormone therapy and vasomotor symptoms after the Women's Health Initiative.

Crawford SL.

Menopause. 2014 May;21(5):439-41. doi: 10.1097/GME.0000000000000228. No abstract available.

PMID:
24667356
5.

[Coronary heart disease mortality and hormone therapy before and after the Women's Health Initiative].

Tuomikoski P, Lyytinen H, Korhonen P, Hoti F, Vattulainen P, Gissler M, Ylikorkala O, Mikkola TS.

Duodecim. 2014;130(21):2209. Finnish. No abstract available.

PMID:
25582016
6.

After the Women's Health Initiative: decision making and trust of women taking hormone therapy.

Schonberg MA, Davis RB, Wee CC.

Womens Health Issues. 2005 Jul-Aug;15(4):187-95.

PMID:
16051110
8.

The impact of the Women's Health Initiative study on incident clonidine use in Ontario, Canada.

Austin PC, Mamdani MM, Tu K.

Can J Clin Pharmacol. 2004 Fall;11(2):e191-4. Epub 2004 Sep 3.

PMID:
15520472
9.

Prevalence and opinions of hormone therapy prior to the Women's Health Initiative: a multinational survey on four continents.

Heinemann K, Rübig A, Strothmann A, Nahum GG, Heinemann LA.

J Womens Health (Larchmt). 2008 Sep;17(7):1151-66. doi: 10.1089/jwh.2007.0584.

PMID:
18774896
10.

A personal initiative for women's health: to challenge the Women's Health Initiative.

Genazzani AR, Gambacciani M.

Gynecol Endocrinol. 2002 Aug;16(4):255-7. No abstract available.

PMID:
12396552
11.

From the challenge to the reassessment of the Women's Health Initiative: a personal initiative for women's health.

Gambacciani M, Genazzani AR.

Gynecol Endocrinol. 2006 Mar;22(3):115-6. No abstract available.

PMID:
16835071
12.

Effect of the Women's Health Initiative on women's decisions to discontinue postmenopausal hormone therapy.

Ettinger B, Grady D, Tosteson AN, Pressman A, Macer JL.

Obstet Gynecol. 2003 Dec;102(6):1225-32.

PMID:
14662208
13.

Tipping the balance: the WHI study and the benefits and risks of hormone replacement therapy. Women's Health Initiative.

Collins JA.

J Obstet Gynaecol Can. 2002 Sep;24(9):683-8. English, French. No abstract available.

PMID:
12360360
14.

Trends in hormone therapy use before and after publication of the Women's Health Initiative trial: 10 years of follow-up.

Barbaglia G, Macià F, Comas M, Sala M, del Mar Vernet M, Casamitjana M, Castells X.

Menopause. 2009 Sep-Oct;16(5):1061-4. doi: 10.1097/gme.0b013e3181a02b44.

PMID:
19369903
15.

The Woman's Health Initiative and one of many unintended consequences.

Simon JA.

Menopause. 2016 Oct;23(10):1057-9. doi: 10.1097/GME.0000000000000749. No abstract available.

PMID:
27623202
16.
17.

HRT use among women tested for BRCA1/2 mutations following publication of the women's health initiative study results.

Vallée MH, Rouleau I, Chiquette J, Plante M, Simard J, Dorval M.

J Obstet Gynaecol Can. 2005 Apr;27(4):321; author reply 322. No abstract available.

PMID:
15937602
18.

Dramatic change in prescribing of hormone replacement therapy in The Netherlands after publication of the Million Women Study: a follow-up study.

Faber A, Bouvy ML, Loskamp L, van de Berg PB, Egberts TC, de Jong-van den Berg LT.

Br J Clin Pharmacol. 2005 Dec;60(6):641-7.

19.

Hormones down under: hormone therapy use after the Women's Health Initiative.

Travers C, O'Neill SM, Khoo SK, King R.

Aust N Z J Obstet Gynaecol. 2006 Aug;46(4):330-5.

PMID:
16866795
20.

Health system responses to the Women's Health Initiative findings on estrogen and progestin: organizational response.

Hartsfield CL, Connelly MT, Newton KM, Andrade SE, Wei F, Buist DS.

J Natl Cancer Inst Monogr. 2005;(35):113-5.

PMID:
16287896

Supplemental Content

Support Center